онкология

1857 проекта

FP7Реинтеграция2013–2017Турция

TRIGBM · Identification of TRAIL sensitivity/resistance mechanisms and searching for novel TRAIL-sensitizing agents in Glioblastoma Multiforme

FP7Реинтеграция2013–2017Нидерландия

BLADDER CANCER EPID · Nutrition and Bladder Cancer

FP7Реинтеграция2013–2017Белгия

METABOLISMCONNECT · Can metabolic states induced by diabetes and obesity promote cancer?

FP7Обмен на изследователи2013–2017Испания

AIDPATH · Academia and Industry Collaboration for Digital Pathology

11 партньори · 8 държави

FP7Реинтеграция2013–2017Франция

LSD1 IMPACT · Dissecting the interaction network of the histone demethylase LSD1 in vivo

FP7Реинтеграция2013–2017Франция

PRONO · Notch and epithelial proliferation

FP7Реинтеграция2013–2017Обединеното кралство

SERPLUC · Suppression of Enzymes Required for Progression of LUng Cancer

FP7Реинтеграция2013–2017Израел

SMURF2 IN CANCER · Molecular mechanisms of tumor suppressor functions of HECT-type E3 ligase Smurf2: roles in chromatin organization, dynamics, gene expression and DNA damage response and repair

FP7Реинтеграция2013–2017Испания

GLYCODRUGS · new strategies for controlling the activity of glycosidase enzymes and their application in therapies for lysosomal storage diseases and cancer

FP7Индивидуална стипендия2013–2015Швеция

NCAT · Nudix hydrolases in Cancer Therapy

FP7Индивидуална стипендия2013–2015Обединеното кралство

ImageMelTherapyLRI · Single cell level intravital imaging of response, tolerance, and resistance to targeted therapies

2 партньори

FP7Индивидуална стипендия2013–2015Франция

MKlp2-mitosis · MKlp2 - a mitotic kinesin and a prime target for cancer therapy

FP7Реинтеграция2013–2017Австрия

BERG · Biomedical Epigenomics Research Group

FP7Реинтеграция2013–2017Израел

HSCSPECDDR · Elucidation of DNA Damage Response mechanisms in human normal and leukemia stem cells

FP7Реинтеграция2013–2017Германия

BONEMETTNC · Analysis of Tenascin C function in breast cancer metastasis to bone

FP7Реинтеграция2013–2017Испания

PRR IN IMMUNOTHERAPY · COMBINATIONAL USE OF INNATE IMMUNE RECEPTORS FOR CANCER IMMUNOTHERAPY

FP7Индивидуална стипендия2013–2015Австрия

BB: DICJI · Breaking barriers: Investigating the junctional and mechanobiological changes underlying the ability of Drosophila immune cells to invade an epithelium

FP7Индивидуална стипендия2013–2015Франция

SMPHS · Improved Statistical Monitoring Procedures for Attributes with Applications in Public Health Surveillance

FP7Реинтеграция2013–2017Обединеното кралство

TAMIRCRT · Targeting microRNAs for ColoRectal Cancer Therapy

2 партньори

FP7Индивидуална стипендия2013–2015Норвегия

HYPERTAM · Evaluation of the synergy between tamoxifen chemotherapy and hypericin photodynamic action, following mitochondrial complex III photo-inhibition: Towards a combinatorial anticancer treatment modality

FP7Индивидуална стипендия2013–2015Нидерландия

GENE · Genomic screening of the Embryo for Novel targets in the tumor Endothelium

FP7Реинтеграция2013–2017Испания

PERSMEDOMICS · Bioinformatics and Integrative Genomics for a Novel Personalized Cancer Therapy

FP7Реинтеграция2013–2016Белгия

CHAMELEO · Cellular Hypoxia Alters DNA Methylation through Loss of Epigenome Oxidation

FP7Индивидуална стипендия2013–2015Обединеното кралство

BLMCOMPLEX · Mechanism of Holliday junction dissolution by the Bloom’s Syndrome complex

2 партньори